恶性肿瘤的个性化治疗的研究进展
摘要
没有完全相同的两个肿瘤，因此肿瘤的治疗需遵循一个患者一种治疗方案的原则，即肿瘤的个性化治疗。目前对肿瘤治疗方面的研究包括基因、蛋白质、信号转导、代谢通路等，这些都与肿瘤药物治疗的反应性、预后、治疗效果判断及药物抵抗、不良反应等相关。因此，
出处
《检验医学与临床》
CAS
2013年第A01期180-182,共3页
Laboratory Medicine and Clinic
参考文献10
-
1Williams RJ. Biochemical individuality: the Basis for the Genetotrophic Concept [M], New York: John Wiley Sons,Inc. ,1956,24(18) :195.
-
2Yoshida K,Tanabe K, Ueno H, et al. Future prospects of personalized chemotherapy in gastric cancer patients:re- sults of a prospective randomized pilot study[J]. Gastric Cancer,2003,6(Suppl 1) :82-89.
-
3Popat S, Matakidou A, Houlston RS. Thymidylate syn- thase expression and prognosis in colorectal cancer: A systematic review and m e-ta-analysis[J]. Journal of Clin- ical Oncology, 2004,22 (3) : 529-536.
-
4Lynch T J, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying re- sponsiveness of non-small-cell lung cancer to gefitinib[J]. The New England Journal of Mediene, 2004, 350(21): 2129-2139.
-
5Sakamuro D, Sabbatini P,White E, et al. The polyproline region of p53 is required to activate apoptosis but not growth arrest[J]. Oncogene, 1997,15(8) :887-898.
-
6Tsourouflis G,Theocharis SE,Sampani A,et al. Prognos- tic and predictive value of thymidylate synthase expres- sion in colon caneer[J]. Digestive Diseases and Sciences, 2008,53(5) : 1289-1296.
-
7Reinmuth N, Bran& B, Kunze WP, et al. Ploidy, expres- sion of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung eancer[J]. Europe- an Respiration Journal,2000,16(5) 991-996.
-
8Bocca C, Bozzo F, Gabriel L, et al. Conjugated linoleic acid inhibits Caco-2 cell growth via ERK-MAPK signaling pathway [ J ]. The Journal of Nutritional Biochemistry, 2007,18(5) : 332-340.
-
9Sasano H, Suzuki T, Nakata T, et al. New Development inintracrinology of breast carcinoma [J]. Breast Cancer, 2006,13 (2) : 129-136.
-
10Ichikawa W. Prediction of clinical outcome of fluoropyri- midine-based chemotherapy for gastric cancer patients,in terms of the 5-fluorouracil metabolic pathway[J]. Gastric Cancer, 2006,9 (3) : 145-155.
-
1张海澄.肺栓塞的心电图表现及机制[J].临床心电学杂志,2003,12(2):69-70. 被引量：71
-
2姚莹.急性肺栓塞心电图表现分析[J].医学综述,2006,12(8). 被引量：1
-
3高洁,耿晓雯,吕中华,程庆强,任艺虹.血栓弹力图指导下的替格瑞洛与氯吡格雷在急性冠脉综合征患者中的疗效比较[J].中华老年多器官疾病杂志,2016,15(5):353-357. 被引量：5
-
4王明亮,朱毅,甘洁民.急性冠脉综合征患者中氯吡格雷抵抗的发生率及影响因素[J].中国临床药学杂志,2010,19(3):142-144. 被引量：6
-
5韩莹,冯力,李明星,胡永毅,冯涛.替格瑞洛对冠心病血小板药物抵抗患者的治疗作用[J].中国老年学杂志,2014,34(9):2393-2394. 被引量：13
-
6季惠.高龄老年冠心病患者阿司匹林抵抗的相关因素分析[J].大家健康（学术版）,2015(23).
-
7HIV感染的青少年存在较高的原发性药物抵抗[J].传染病网络动态,2007(2):9-9.
-
8马建新.肺栓塞心电图ST段主要改变、鉴别诊断及其可能机制[J].心电图杂志（电子版）,2015,4(1):9-10. 被引量：3
-
9倪淑红,钱玲妃.急性肺栓塞患者心电图变化及其诊断价值[J].现代中西医结合杂志,2007,16(34):5171-5172.
-
10彭勃,苗明三,杨晓娜.中医药治疗艾滋病的研究进展[J].河南中医,2006,26(1):82-85. 被引量：35
